Why the study?
Cardiovascular disease risk increases in children with chronic kidney disease, particularly with low serum 25-hydroxyvitamin D levels, but the vascular effects of cholecalciferol across dialysis modalities were unclear.
Does a single dose of cholecalciferol improve endothelial function and vascular stiffness in children with CKD and vitamin D deficiency?
Does a single dose of cholecalciferol improve endothelial function and vascular stiffness in children with CKD and vitamin D deficiency?
Cholecalciferol therapy improves endothelial dysfunction in children with CKD and vitamin D deficiency, suggesting vitamin D should be corrected early to prevent cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for cholecalciferol effects on vascular function in pediatric CKD; randomized trials needed before practice change.
ABSTRACT Objective: The risk of developing cardiovascular disease (CVD) increases significantly in children with chronic kidney disease (CKD) especially with low serum 25- hydroxyvitamin D (25OHD) levels. Herein; we aimed to compare the effects of vitamin D deficiency and the impact of cholecalciferol treatment on endothelial functions and vascular stiffness in children with CKD receiving hemodialysis (HD), peritoneal dialysis (PD) and non- dialysis(ND). Methods: 7 HD, 7 PD and 27 ND patient groups consisting of 41 children totally with low 25OHD levels were compared among each other in regards of biochemical parameters, flow-mediated dilatation(FMD) and local arterial stiffness before and after a single dose of 300.000 units of cholecalciferol treatment. Results: There was no difference in FMD and local arterial stiffness values between HD, PD and ND patient groups before vitamin D supplementation. Significant increase in endothelium-dependent FMD was observed in all patient groups after intervention with cholecalciferol; however the improvement in endothelium-independent FMD and local arterial stiffness measurements was demonstrated in patients with PD and ND. Baseline parathormon level was higher in patients on dialysis; at the end of the study, significant decrease was detected only in patient group not receiving diaysis. Conclusions: Endothelial dysfunction and impaired vascular stiffness were determined in children with CKD with low 25OHD levels regardless of the disease severity.. Recovery with cholecalciferol therapy revealed that vitamin D deficiency should be corrected even in early stages of CKD to prevent the development of CVD
No takes yet. Share an insight, caveat, or question.
Aytaç et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: